Cyclacel Pharmaceuticals, Inc. ( CYCC) - Key Metrics
Stock symbol CYCC is outdated, potentially delisted? Maybe it is available on other exchange?
CYCC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q2 | ? | ? | ? | ? |
| 2025Q1 | ? | -$6.25 | -$0.25 | -$0.25 |
| 2024Q4 | $0 | -$0.35 | -$0.16 | -$0.16 |
| 2024Q3 | $0 | -$0.97 | -$1.52 | -$1.52 |
| 2024Q2 | $0 | -$1.92 | -$1.82 | -$1.82 |
CYCC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q2 | -3.11% | ? |
| 2025Q1 | ? | -2.68 |
| 2024Q4 | ? | -64.05 |
| 2024Q3 | ? | -61.24 |
| 2024Q2 | ? | -50.51 |
CYCC Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q2 | ? | ? |
| 2025Q1 | -0.37% | ? |
| 2024Q4 | -0.17% | ? |
| 2024Q3 | -0.64% | ? |
| 2024Q2 | -0.47% | ? |
CYCC
Price: $6.36
52 week price:
Dividend Yield: 2.01%
Forward Dividend Yield: 2.36%
Payout Ratio Range:
Dividend Per Share: 0.15 USD
Earnings Per Share: 7123.50 USD
P/E Ratio: 0.18
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 123100
Ebitda: -2.1 millionMarket Capitalization: 12.4 million
Years Paying Dividends: 1